Who we are
Delivering on our promise for patients
Founded in 1999 in Copenhagen, Denmark, we are a dual-listed, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics to fight against cancer and other serious diseases.
An experienced international management team sets the direction for our growth. Our proprietary product pipeline and next-generation antibody technologies result from a strong company culture and passion for innovation. We are rooted in science and inspired by patients.